Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/VA/Fredericksburg
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fredericksburg, VA

Studies commonly pay $75 to $4,500 per completed study

34 clinical trials are currently recruiting participants within 30 miles of Fredericksburg. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

34studies recruiting
7+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Fredericksburg right now

Top 25 of 34 recruiting studies, sorted by proximity — each links to its official registry page

A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

Chronic Kidney Disease and Hypertension Phase 2 Interventional 218 participants sought
Research Site — Woodbridge, Virginia (27.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07222917)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06418204)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05896189)

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Acute Coronary Syndrome Phase 3 Interventional 2,000 participants sought
Research Site — Fredericksburg, Virginia (1.5 mi) · Sponsor: DalCor Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05918861)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Phase 3 Interventional 320 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06524544)

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

Chronic Kidney Disease and Hypertension Phase 3 Interventional 5,000 participants sought
Research Site — Woodbridge, Virginia (27.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06742723)

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

Follicular Lymphoma Phase 3 Interventional 400 participants sought
Hematology Oncology Associates of Fredericksburg — Fredericksburg, Virginia (1.5 mi) · Sponsor: Celgene
See eligibility & contact on ClinicalTrials.gov (NCT06911502)

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Atrial Fibrillation (AF) Phase 3 Interventional 2,500 participants sought
Anthos Investigational site 9817 — Fredericksburg, Virginia (1.5 mi) · Sponsor: Anthos Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05712200)

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Relapsed or Refractory Multiple Myeloma Phase 3 Interventional 810 participants sought
Local Institution - 0297 — Fredericksburg, Virginia (1.5 mi) · Sponsor: Celgene
See eligibility & contact on ClinicalTrials.gov (NCT05519085)

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2 Interventional 66 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05642572)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,260 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06931340)

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2 Interventional 56 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06031688)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05879926)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Mary Washington Hospital ( Site 0129) — Fredericksburg, Virginia (1.5 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06498635)

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2, Phase 3 Interventional 378 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06616584)

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Breast Cancer, Metastatic Breast Cancer Phase 3 Interventional 404 participants sought
Hematology-Oncology Associates of Fredericksburg, Inc — Fredericksburg, Virginia (1.5 mi) · Sponsor: BriaCell Therapeutics Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06072612)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Fredericksburg, Virginia (1.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Extensive-stage Small-cell Lung Cancer Phase 3 Interventional 621 participants sought
Hematology Oncology Associates of Fredericksburg, Inc. — Fredericksburg, Virginia (1.5 mi) · Sponsor: BioNTech SE
See eligibility & contact on ClinicalTrials.gov (NCT06712355)

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Stage III Colon Cancer Phase 2, Phase 3 Interventional 1,912 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05174169)
Google-rated

Top-rated research centers in Fredericksburg

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

C & C Research Inc

★ 4.3
137 Spotsylvania Mall Dr, Fredericksburg, VA 22407
(540) 479-1814
"Great way to make extra cash!! They have a variety of surveys you can do. Ranging from $2 to $350 Food, skincare products, and drinks. Some surveys y…"
— rraygen w, 5★

Charlottesville Medical Research

★ 4.8
325 Winding River Ln #102, Charlottesville, VA 22911
(434) 817-2442
"Friendly and proficient staff all around."
— Wayne Ayers, 5★

Accell Clinical Research, LLC

★ 2.0
7551 Foxview Dr, Warrenton, VA 20186
"I've had the same experience as everyone else who has left reviews. The person who contacted me was Jessica Bush and the man doing the "interview" w…"
— Michele, 1★

National Clinical Research

★ 5.0
2809 Emerywood Pkwy #140, Richmond, VA 23294
(804) 672-2995

Clinical Research Partners

★ 4.9 (66 reviews)
7110 Forest Ave, Richmond, VA 23226
(804) 477-3045
"This was a really friendly environment. Piyali made the process very smooth and was so kind and friendly. Any worries I had she addressed and made me…"
— YoshiRocker 7, 5★

Velocity Clinical Research

★ 4.1 (43 reviews)
1201 Seven Locks Rd Ste 214, Rockville, MD 20854
(240) 698-2800
"This place stay away from do not come here for a clinical research they will try to and will rip you off on paying you completely for your visits the…"
— Wanda Banville, 1★

MD Medical Research

★ 4.9
6357 Oxon Hill Rd Fl 2, Oxon Hill, MD 20745
(301) 329-2612
"Maluu is so kind and professional ❤️"
— Tiffany West, 5★

Clinical trials in Fredericksburg: what's recruiting

The Fredericksburg area currently has 34 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fredericksburg, the most active research areas are:

  • Cancer & Oncology20 studies
  • Heart & Vascular3 studies
  • Liver & Kidney3 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Fredericksburg, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fredericksburg

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fredericksburg participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Fredericksburg?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Fredericksburg safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Fredericksburg?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Fredericksburg?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fredericksburg.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fredericksburg typically complete one or two studies per year.

Paid clinical trials near Fredericksburg

Other metros within reach

Alexandria, VA2,303 Arlington, VA2,345 Washington, DC2,376 Richmond, VA620 Frederick, MD261 Baltimore, MD1,648 Hagerstown, MD112 Newport News, VA384

More of VA

Arlington2,345 Alexandria2,303 Richmond620 Chesapeake408 Virginia Beach407 Norfolk407 Newport News384 Roanoke200

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts